[YINSON] QoQ Annualized Quarter Result on 31-Jul-2021 [#2]

Stock
[YINSON] YINSON HOLDINGS BHD
Announcement Date
23-Sep-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jan-2022
Quarter
31-Jul-2021 [#2]
Profit Trend
QoQ- 6.25%
YoY- 61.83%
Quarter Report
Latest QR
Upcoming QR
YINSON's Result
YINSON's Financial Summary
View:
Show?
Annualized Quarter Result
30/04/22 31/01/22 31/10/21 31/07/21 30/04/21 31/01/21 31/10/20 CAGR
Revenue 4,020,000 3,607,000 3,821,333 4,092,000 3,968,000 4,849,000 4,802,188 -11.20%
PBT 760,000 716,000 748,000 790,000 748,000 580,000 563,126 22.19%
Tax -204,000 -192,000 -174,666 -182,000 -168,000 -168,000 -148,876 23.43%
NP 556,000 524,000 573,333 608,000 580,000 412,000 414,250 21.74%
-
NP to SH 480,000 401,000 448,000 476,000 448,000 315,000 330,401 28.36%
-
Tax Rate 26.84% 26.82% 23.35% 23.04% 22.46% 28.97% 26.44% -
Total Cost 3,464,000 3,083,000 3,248,000 3,484,000 3,388,000 4,437,000 4,387,937 -14.61%
-
Net Worth 5,647,719 2,332,792 2,215,489 2,162,485 2,024,292 1,780,219 1,856,950 110.34%
Dividend
30/04/22 31/01/22 31/10/21 31/07/21 30/04/21 31/01/21 31/10/20 CAGR
Div - 63,912 56,807 85,221 - 63,960 58,257 -
Div Payout % - 15.94% 12.68% 17.90% - 20.30% 17.63% -
Equity
30/04/22 31/01/22 31/10/21 31/07/21 30/04/21 31/01/21 31/10/20 CAGR
Net Worth 5,647,719 2,332,792 2,215,489 2,162,485 2,024,292 1,780,219 1,856,950 110.34%
NOSH 2,207,565 1,101,346 1,099,812 1,099,737 1,099,717 1,099,519 1,098,384 59.46%
Ratio Analysis
30/04/22 31/01/22 31/10/21 31/07/21 30/04/21 31/01/21 31/10/20 CAGR
NP Margin 13.83% 14.53% 15.00% 14.86% 14.62% 8.50% 8.63% -
ROE 8.50% 17.19% 20.22% 22.01% 22.13% 17.69% 17.79% -
Per Share
30/04/22 31/01/22 31/10/21 31/07/21 30/04/21 31/01/21 31/10/20 CAGR
RPS 188.62 338.62 358.76 384.13 372.44 454.88 439.63 -43.20%
EPS 22.40 37.60 42.00 44.60 42.00 29.50 30.25 -18.19%
DPS 0.00 6.00 5.33 8.00 0.00 6.00 5.33 -
NAPS 2.65 2.19 2.08 2.03 1.90 1.67 1.70 34.55%
Adjusted Per Share Value based on latest NOSH - 1,099,737
30/04/22 31/01/22 31/10/21 31/07/21 30/04/21 31/01/21 31/10/20 CAGR
RPS 125.43 112.55 119.23 127.68 123.81 151.30 149.84 -11.20%
EPS 14.98 12.51 13.98 14.85 13.98 9.83 10.31 28.37%
DPS 0.00 1.99 1.77 2.66 0.00 2.00 1.82 -
NAPS 1.7622 0.7279 0.6913 0.6747 0.6316 0.5555 0.5794 110.34%
Price Multiplier on Financial Quarter End Date
30/04/22 31/01/22 31/10/21 31/07/21 30/04/21 31/01/21 31/10/20 CAGR
Date 29/04/22 31/01/22 29/10/21 30/07/21 30/04/21 29/01/21 30/10/20 -
Price 2.45 5.50 5.85 4.78 5.22 5.20 4.58 -
P/RPS 1.30 1.62 1.63 1.24 1.40 1.14 1.04 16.08%
P/EPS 10.88 14.61 13.91 10.70 12.41 17.60 15.14 -19.81%
EY 9.19 6.84 7.19 9.35 8.06 5.68 6.60 24.77%
DY 0.00 1.09 0.91 1.67 0.00 1.15 1.16 -
P/NAPS 0.92 2.51 2.81 2.35 2.75 3.11 2.69 -51.19%
Price Multiplier on Announcement Date
30/04/22 31/01/22 31/10/21 31/07/21 30/04/21 31/01/21 31/10/20 CAGR
Date 23/06/22 29/03/22 17/12/21 23/09/21 25/06/21 25/03/21 21/12/20 -
Price 2.11 4.49 5.60 4.90 5.00 5.40 5.42 -
P/RPS 1.12 1.33 1.56 1.28 1.34 1.19 1.23 -6.07%
P/EPS 9.37 11.93 13.31 10.97 11.89 18.27 17.92 -35.17%
EY 10.67 8.38 7.51 9.12 8.41 5.47 5.58 54.24%
DY 0.00 1.34 0.95 1.63 0.00 1.11 0.98 -
P/NAPS 0.80 2.05 2.69 2.41 2.63 3.23 3.19 -60.33%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment